Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

JPMorgan raises ESAB stock target to $125, upgrades to overweight

EditorAhmed Abdulazez Abdulkadir
Published 18/03/2024, 10:20
Updated 18/03/2024, 10:20
© Reuters

On Monday, JPMorgan (NYSE:JPM) made a positive adjustment to ESAB Corporation's (NYSE:ESAB) stock, upgrading the rating from Neutral to Overweight and increasing the price target to $125.00 from the previous $111.00. The firm anticipates ESAB to become a growth compounder, expecting high-teens percentage earnings per share (EPS) growth through 2028.

The upgrade comes with a forecast of at least long-term mid-single-digit percentage (LTMSD%) upside to consensus EPS estimates, driven by potential mergers and acquisitions (M&A) activity in 2024.

The analyst highlighted ESAB's organic sales growth guidance for 2024, which ranges from 2.5% to 4.5%. This forecast is considered conservative, especially when compared to Illinois Tool Works Inc.'s (NYSE:ITW) Welding segment, which projects 3-5% growth, and Lincoln Electric Holdings Inc . (NASDAQ:LECO), which is not covered by the analyst but is expected to have LTMSD% growth for the fiscal year 2024.

ESAB's focus on high-growth markets such as India and the Middle East is also seen as a strategic advantage that could drive organic growth acceleration beyond 2024, with approximately 40% of its business mix targeted towards these higher growth end markets.

The new price target of $125 is based on approximately 24 times the fiscal year one (FY1) price-to-earnings (PE) ratio, which is about two times lower than that of LECO, its larger peer. The valuation also includes the assumption of a 22 times FY1 PE ratio, considering LTMSD% EPS accretion annually from potential M&A activities. ESAB's current trading at around 21 times FY1 consensus estimates suggests there is room for a valuation re-rate.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

JPMorgan believes ESAB should command a 10-20% premium compared to the market, recognizing its potential as a growth compounder in the medium to long term.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.